Demant A/S (OTCMKTS:WILYY) Cut to Hold at Sanford C. Bernstein

Sanford C. Bernstein lowered shares of Demant A/S (OTCMKTS:WILYY) from a strong-buy rating to a hold rating in a report issued on Friday morning,Zacks.com reports.

Several other research analysts have also commented on WILYY. Morgan Stanley upgraded Demant A/S from an “equal weight” rating to an “overweight” rating in a research report on Tuesday, June 23rd. Zacks Research raised Demant A/S to a “hold” rating in a research report on Friday, June 26th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Demant A/S Price Performance

Shares of Demant A/S stock opened at $20.66 on Friday. The business has a 50-day moving average price of $19.43 and a 200 day moving average price of $16.86. Demant A/S has a fifty-two week low of $13.45 and a fifty-two week high of $20.98. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.36 and a quick ratio of 1.00.

About Demant A/S

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.